Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SENP1 | Q9P0U3 | 2/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 0.83 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.81 |
| ▸ | PTPN1 | P18031 | 9/20 | 0.78 |
| ▸ | PYGM | P11217 | 2/20 | 0.73 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.73 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.73 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | USP7 | Q93009 | 1/20 | 0.73 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.71 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.71 |
| ▸ | GABRP | O00591 | 1/20 | 0.61 |
| ▸ | GABRD | O14764 | 1/20 | 0.61 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.61 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.61 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.61 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.61 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Euscaphic Acid SCHEMBL7349271 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL29228689 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL17584886 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL126037 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL869457 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL13629633 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL5971379 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL7349266 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL5799713 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM | |
| Euscaphic Acid SCHEMBL869924 | 1.00 | SENP1 (1.00) | SENP1ACHEHSD11B1PTPN1PYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605351-B2 | Method for producing a composition comprising a 3-O-p-coumaroyl ester of tormentic acid from a plant cell culture, applications thereof as antiparasitic agent for the treatment of trypanosomiasis | LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LU) | 2026-04-21 | — | — | US | claimed |
| US-12514892-B1 | Scar revisions using topical Hamelia patens extract | BERRY DON WAYNE (US) | 2026-01-06 | — | — | US | claimed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4630026-A1 | COMPOSITIONS COMPRISING SANGUISORBA OFFICINALIS ROOT EXTRACT AND USES THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2025-10-15 | — | — | EP | claimed |
| CN-120202013-A | Composition containing sanguisorba officinalis root extract and application thereof | 科莱恩国际有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119367374-A | Potentilla acid compound as CB2 receptor agonist, medicament and application | 赣江中药创新中心 | 2025-01-28 | — | — | CN | claimed |
| CN-119302965-A | Application of tormentic acid in preparation of products for preventing and treating hypertension | 福建中医药大学 | 2025-01-14 | — | — | CN | claimed |
| CN-118660707-A | Supermolecule self-assembly system | 北京睿创康泰医药研究院有限公司 | 2024-09-17 | — | — | CN | claimed |
| WO-2024120853-A1 | COMPOSITIONS COMPRISING SANGUISORBA OFFICINALIS ROOT EXTRACT AND USES THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2024-06-13 | — | — | WO | claimed |
| CN-118047822-A | Compound extracted from elm bark, and preparation method and application thereof | 延边大学 | 2024-05-17 | — | — | CN | claimed |
| WO-2006064583-A1 | TERPENE, METHOD FOR DETERMINING ITS BLOOD CONCENTRATION, AND METHOD FOR ANALYZING ITS PHARMACOKINETICS | USE-TECHNO CORPORATION (JP) | 2006-06-22 | — | — | WO | claimed |
| WO-2006054370-A1 | GLUCONEOGENESIS INHIBITING AGENT | USE-TECHNO CORPORATION (JP) | 2006-05-26 | — | — | WO | claimed |
| WO-2006019881-A2 | COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS AND BACTERIAL INFECTIONS | ELDRIDGE GARY R (US) | 2006-02-23 | — | — | WO | claimed |
| WO-2006010147-A2 | CONTROL OF BIOFILM FORMATION | ELDRIDGE GARY R (US) | 2006-01-26 | — | — | WO | claimed |
| US-20050267055-A1 | Agent for improvement of glucose tolerance | USE-TECHNO CORPORATION | 2005-12-01 | — | — | US | claimed |
| US-20050255569-A1 | Method for producing triterpene composition | USE-TECHNO CORPORATION | 2005-11-17 | — | — | US | claimed |
| EP-1569668-A1 | AN ORGANIC EXTRACT OF GEUM JAPONICUM THUMB VARIANT AND USE THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (HK) | 2005-09-07 | — | — | EP | claimed |
| WO-2004052381-A1 | AN ORGANIC EXTRACT OF GEUM JAPONICUM THUMB VARIANT AND USE THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2004-06-24 | — | — | WO | claimed |
| EP-1355642-A2 | INHIBITION OF NF-(k)B BY TRITERPENE COMPOSITIONS | RESEARCH DEVELOPMENT FOUNDATION (US) | 2003-10-29 | — | — | EP | claimed |
| WO-2002055016-A2 | INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS | RES DEV FOUNDATION (US) | 2002-07-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | S100A8, TP53, AQP1 | SENP1 2358/4885ACHE 544/4885HSD11B1 810/4885 |
| US-12605351-B2 | Method for producing a composition comprising a 3-O-p-coumaroyl ester of tormentic acid from a plant cell culture, applications thereof as antiparasitic agent for the treatment of trypanosomiasis | NFATC1, CYP51A1, ME1 | SENP1 1598/4885ACHE 2221/4885HSD11B1 261/4885 |
| US-20050267055-A1 | Agent for improvement of glucose tolerance | GPR119, GYS2, GCKR | SENP1 2872/4885ACHE 3845/4885HSD11B1 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.